Standout Papers

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer 2004 2026 2011 2018 4.3k
  1. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer (2004)
    Ian F. Tannock, Ronald de Wit et al. New England Journal of Medicine

Immediate Impact

5 by Nobel laureates 28 from Science/Nature 89 standout
Sub-graph 1 of 19

Citing Papers

Androgen receptor activity in T cells limits checkpoint blockade efficacy
2022 StandoutNature
Prostate cancer
2021 Standout
59 intermediate papers

Works of J Horti being referenced

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitor
1999
and 2 more

Author Peers

Author Last Decade Papers Cites
J Horti 3561 1592 995 1155 17 4.5k
William R. Berry 3834 1755 962 1244 22 4.8k
Mary Ellen Taplin 4080 1528 911 950 27 5.0k
Bryan Selby 3215 905 838 1106 10 3.6k
Liji Shen 2728 1240 607 1099 35 3.4k
Mohammad Hirmand 4529 1309 1160 1623 38 5.1k
Ivo Kocák 2416 1363 706 926 40 3.2k
Jean-Pascal Machiels 2365 1999 942 1004 36 4.4k
Susan Feyerabend 3080 977 712 974 71 3.7k
Steinbjørn Hansen 3036 1700 1489 1311 88 5.5k
Martin Roessner 2190 948 499 887 11 2.8k

All Works

Loading papers...

Rankless by CCL
2026